Clinical Trial Serious Adverse Event Report -Phase 1-4  AMGEN  □New  
Nodfy Amgen Wimln 24 Hours of knowledge of the evenz  CC-10004-P80R-020  
□Follow-up  Apremlla(Olezla}  
Reminder:Enarhe SAEmomadon no AVE and men 56nd mepaperSerous  
AmunrcapmnTDonn.  
